Related Experiment Video
Updated: Jul 12, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
The scientific basis of tobacco product regulation
Abstract:
This report presents the conclusions reached and recommendations made by the members of the WHO Study Group on Tobacco Product Regulation at its third meeting, during which it reviewed four background papers specially commissioned for the meeting and which dealt, respectively, with the following four themes. 1. The contents and design features of tobacco products: their relationship to dependence potential and consumer appeal. 2. Candy-flavoured tobacco products: research needs and regulatory recommendations. 3. Biomarkers of tobacco exposure and of tobacco smoke-induced health effects. 4. Setting maximum limits for toxic constituents in cigarette smoke. The Study Group's recommendations in relation to each theme are set out at the end of the section dealing with that theme; its overall recommendations are summarized in section 6.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Drug Regulation
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Criteria for Causality: Bradford Hill Criteria - II
Drug Control Governance: Regulatory Bodies and Their Impact
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...